Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.331,71
-1,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elevation Oncology Inc (ELEV) Elevation Oncology Inc (ELEV) Notizie

Elevation Oncology Inc

ELEV
4,0485
0,4985 (14,04%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/4/202422:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
06/3/202414:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202413:45EDGAR2Form 8-K - Current report
06/3/202413:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
06/3/202413:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
04/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202413:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
28/2/202413:30PRNUSElevation Oncology to Participate in Upcoming Investor..
22/2/202413:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
20/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202422:15EDGAR2Form 8-K - Current report
22/1/202422:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202413:45EDGAR2Form 8-K - Current report
22/1/202413:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
09/1/202422:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202413:40EDGAR2Form 8-K - Current report
05/1/202413:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
22/11/202313:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
02/11/202312:45EDGAR2Form 8-K - Current report
02/11/202312:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
02/11/202312:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/9/202322:30EDGAR2Form 8-K - Current report
05/9/202313:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
16/8/202313:45EDGAR2Form 8-K - Current report
16/8/202313:30PRNUSElevation Oncology Announces First Patient Dosed in the..
03/8/202313:45EDGAR2Form 8-K - Current report
03/8/202313:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
03/8/202313:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202313:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/7/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202322:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/7/202314:15EDGAR2Form 8-K - Current report
13/7/202314:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..
09/6/202304:41PRNUSElevation Oncology Announces Pricing of $50 Million Public..
08/6/202322:01PRNUSElevation Oncology Announces Launch of Proposed Public..
03/6/202315:00PRNUSElevation Oncology Highlights First-in-Human Phase 1..
15/5/202313:30PRNUSElevation Oncology Reports First Quarter 2023 Financial..
Apertura: 3,59 Min: 3,43 Max: 4,48
Chiusura: 3,55

La tua Cronologia

NASDAQ
ELEV
Elevation Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network